Latest filing published 04 Mar 2026 for Vanda Pharmaceuticals Inc., €216k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Joakim Wijkstrom is a declared insider of Vanda Pharmaceuticals Inc. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 20 August 2021 to 2 March 2026, the count stands at 12 filings.
The open-market record consists of 6 sales worth €397k, with no purchase. Besides market trades, the filings include 6 share grants. In 2026 alone, the filings show no purchases and 1 sale.
The latest filing, published on 4 March 2026, reports an open-market sale of €216k in Vanda Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations